Patent-infringement suits target the act of making or selling the drug itself, regardless of how its advertised, and can lead to hefty damages awards and court orders blocking sales
Submits FDA Filing July 14, 2022 26th worldwide patent and the first patent issued from Lexarias seventh patent family Lexarias Human Nicotine Study Nearing Start Date July 13, 2022 Lexaria is targeting the oral nicotine pouch category, one of the fastest growing segments of the nicotine industry Lexaria Granted Patent for Use of DehydraTECH to Deliver Antiviral Drugs April 21, 2022 25th patent grant is Lexarias first-ever patent for the enhanced delivery of antivirals Lexarias Pulmonary Hypertension Clinical Study HYPER-H21-3 Delivers Positive Results April 14, 2022 Data From This Human Study, Together With the Findings From Lexarias Other Previously Announced Successful Studies, Intended To Support the Companys Plans To Seek Approvals by the U.S
Across all respondents who microdosed, 24 percent said they had been microdosing for six months or more, showing it may be a more sustainable way to tackle weight loss goals
Many people assume this medication will eliminate hunger entirely, but thats not exactly how it works
Hydration support: Replenishes fluids to combat fatigue caused by dehydration